Citius Oncology Inc (TENKU) Annual Balance Sheets

Annual · GAAP · USD millions
Access TENKU quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Citius Oncology Inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent7.30
Cash & Short-term Investments7.00
Accounts receivable4.05
Inventories22.64
Prepaid Expense, Current AS3.16
Total Current Assets37.15
Long-term investments0.00
Other Assets, Noncurrent72.83
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents3.92
Inprocess Research And Development Noncurrent73.40
Total Assets109.97
Liabilities
Accounts Payable, Current AC10.45
Accrued Liabilities, Current AC4.52
Other Notes Payable, Current OT3.80
Other Liabilities, Current25.94
Total Current Liabilities44.71
Total Long-term Debt0.00
Other liabilities, Noncurrent6.85
DeferredIncomeTaxLiabilitiesNet2.78
License Payable22.65
Total Liabilities51.56
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock127.98
Retained Earnings / Accumulated Deficit-69.57
Other Equity0.00
Common Stockholder's Equity58.41
Non-controlling interests & other0.00
Total Stockholder's Equity58.41
Liabilities & Stockholder's Equity109.97
4 historic quarters locked

Sign in to unlock the full Citius Oncology Inc balance sheet history.

About Citius Oncology Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-25-125331

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License